LEADER 03335nam 22006973a 450 001 9910346681703321 005 20250203235435.0 010 $a9783039210497 010 $a3039210491 024 8 $a10.3390/books978-3-03921-049-7 035 $a(CKB)4920000000094852 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/54428 035 $a(ScCtBLL)326b64ac-cd0e-4334-b41b-fb0926874c4e 035 $a(OCoLC)1118512515 035 $a(oapen)doab54428 035 $a(EXLCZ)994920000000094852 100 $a20250203i20192019 uu 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNeonatal Screening for Critical Congenital Heart Defects$fAndrew Ewer 210 $cMDPI - Multidisciplinary Digital Publishing Institute$d2019 210 1$aBasel, Switzerland :$cMDPI,$d2019. 215 $a1 electronic resource (98 p.) 311 08$a9783039210480 311 08$a3039210483 330 $aCritical congenital heart defects (CCHDs) are potentially life-threatening malformations that remain a significant cause of neonatal mortality and morbidity. Failure to diagnose these conditions shortly after birth may result in acute cardiovascular collapse and death. The identification of CCHDs by routine newborn clinical examination is routine in many countries, but consistently misses over a third of cases, and, although antenatal ultrasound screening can be very effective in early diagnosis, the provision and accuracy of ultrasound screening is highly variable. As most CCHDs present with mild cyanosis (hypoxaemia), which is frequently clinically undetectable, pulse oximetry is a rapid, simple, painless method of accurately identifying hypoxaemia, which has gained popularity as a screen for CCHD. This Special Issue of the International Journal of Neonatal Screening, devoted to "Neonatal Screening for Critical Congenital Heart Defects (CCHDs)", will consider the evidence for CCHD screening with pulse oximetry, the acceptability and cost-effectiveness of this intervention, the additional non-cardiac conditions which it may also identify, and international experiences of introducing CCHD screening across the globe. 610 $aaltitude 610 $aCCHD screening in the US 610 $ascreening 610 $acoarctation of aorta 610 $aoxygen saturation 610 $aneonates 610 $acritical congenital heart disease screening 610 $anewborn screening pulse oximetry 610 $ahome births 610 $ahealth policy 610 $acongenital heart disease 610 $aneonatal screening 610 $apulse oximetry 610 $acost-effectiveness 610 $ahypoxia 610 $aneonate 610 $anewborn 610 $acritical congenital heart disease 610 $astate screening 610 $apulse oximetry screening 610 $aeconomic evaluation 610 $ascreening algorithm 610 $anewborn screening 610 $aGermany 610 $acongenital heart defects 700 $aEwer$b Andrew$01331911 801 0$bScCtBLL 801 1$bScCtBLL 906 $aBOOK 912 $a9910346681703321 996 $aNeonatal Screening for Critical Congenital Heart Defects$93040641 997 $aUNINA